ALKBH5 and neoplasm: Additional research has found that the m6A RNA demethylase ALKBH5 affects the accumulation of Tregs and MDSCs in the tumor microenvironment by regulating the expression of Mct4/Slc16a3 and lactate content, thereby influencing the response to anti-PD-1 therapy (92).